Cargando…
What Are Incretins, and How Will They Influence the Management of Type 2 Diabetes?
OBJECTIVES: To review the pathophysiology of type 2 diabetes (T2DM), the role ofincretins, the potential of incretin-based therapies to address unmet therapeuticneeds in T2DM, and the potential impact this will have on the contribution of managed care pharmacy to diabetes therapy. SUMMARY: Diabetes,...
Autores principales: | Bonde, Lawrence, Rosenstock, Julio, Triplitt, Curtis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438057/ https://www.ncbi.nlm.nih.gov/pubmed/16981805 http://dx.doi.org/10.18553/jmcp.2006.12.S7-A.1 |
Ejemplares similares
-
The Changing Landscape of Type 2 Diabetes: The Role of Incretin-Based Therapies in Managed Care Outcomes
por: Triplitt, Curtis, et al.
Publicado: (2007) -
Incretin Mimetics: Promising New Therapeutic Options in the Treatment of Type 2 Diabetes
por: Gleeson, Jeremy M., et al.
Publicado: (2005) -
Canagliflozin Treatment in Patients with Type 2 Diabetes Mellitus
por: Triplitt, Curtis, et al.
Publicado: (2015) -
Incretin hormones and type 2 diabetes
por: Nauck, Michael A., et al.
Publicado: (2023) -
Managing Type 2 Diabetes: Going Beyond Glycemic Control
por: Stolar, Mark W., et al.
Publicado: (2008)